Infographic: Chemical Versus Enzymatic DNA Synthesis

Polymerase-driven synthesis is gaining traction as scientists look to generate longer oligonucleotides and cut back on hazardous waste.

Written byDanielle Gerhard, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

From synthetic biology and gene therapy to data storage and biofuel production, the demand for synthetic DNA is rising.

Chemical synthesis

Phosphoramidite oligonucleotide synthesis is the gold-standard method for generating synthetic DNA. Scientists use the method to assemble modified nucleotides—phosphoramidite nucleosides—with the help of chemicals.1

(1) Chemicals remove the 5’-hydroxyl protecting group.

The nucleosides are rich in exposed hydroxyl and amino groups, so scientists use protecting groups to prevent unintended reactions with compounds used in DNA synthesis. Chemicals remove the protecting groups to facilitate nucleoside coupling.

(2) Chemicals displace the diisopropylamino group.

(3) Chemicals cap unreacted 5’-hydroxyl groups.

An oxidation step creates a more stable coupling. The oligonucleotide is ready for another round of synthesis.

(4) Chemicals stabilize coupling.

Once the oligonucleotide reaches the desired length, additional chemicals remove the remaining protecting groups and cleave the chain from its solid support.

(5) Chemicals cleave the oligonucleotide and remove protecting groups.

(6) Continued exposure to harsh chemicals damages the DNA and reduces yields. Scientists use short oligonucleotides as primers for polymerase chain reaction and next-generation sequencing, in DNA microarrays and fluorescence in situ hybridization, and in antisense therapies.


Enzymatic synthesis

Enzymatic DNA synthesis is an emerging technology that offers several advantages over chemical methods. Scientists use two main approaches to achieve template-independent oligonucleotide assembly.2

(1) Protected deoxynucleotide triphosphate (dNTP) and tethered dNTP approaches both use terminal deoxynucleotidyl transferase (TdT), a unique and specialized DNA polymerase that does not require a primer template to construct DNA.

(2) An incoming protected dNTP or tethered TdT-dNTP conjugate couples to the previously added base.

(3) Mild, aqueous wash reagents.

The deblocking or untethering step is followed by a wash step to remove any lingering reagents, including blocking agents, enzymes, and unbound dNTP. The oligonucleotide is ready for another round of synthesis.

(4) A cleavage reagent separates the oligonucleotide from the base.

Once the desired length is reached, chemicals cleave the oligonucleotide from the solid support.

(5) Reactions occur in mild, aqueous conditions, which limits the use of harsh chemicals that cause DNA damage. Therefore, enzymatic approaches can generate longer strands, such as gene fragments, with a lower error rate.

  1. Hoose A, et al. DNA synthesis technologies to close the gene writing gap. Nat Rev Chem. 2023;7(3):144-161.
  2. Jensen MA, Davis RW. Template-independent enzymatic oligonucleotide synthesis (TiEOS): Its history, prospects, and challenges. Biochemistry. 2018;57(12):1821-1832.

Read the full story.

Related Topics

Meet the Author

  • Black and white photo of Danielle Gerhard

    Danielle is a Senior Editor at The Scientist. She earned her PhD in psychology and behavioral neuroscience from Yale University and completed a postdoctoral fellowship in neuroscience Weill Cornell Medicine. Her research explored the cellular and molecular mechanisms of stress and depression across development. She has served as editor-in-chief of the Yale Journal of Biology and Medicine, contributed stories to BioTechniques News and Drug Discovery News, and engaged in various science outreach initiatives across Connecticut and NYC.

    View Full Profile

Published In

The Scientist's 2024 summer issue cover
Summer 2024

Synthetic Biology is in Fashion

Scientists are pulling on the protein threads that bind textiles and cosmetics together.

Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies